Acyclovir for Oral Herpes in Dentistry

Generic name: Acyclovir / Aciclovir

German term: Aciclovir bei oralem Herpes / Lippenherpes / herpetischer Gingivostomatitis

Category: Antiviral nucleoside analogue active against herpes simplex virus

Dental role: Management support for selected HSV-related oral and perioral lesions, especially early herpes labialis, primary herpetic gingivostomatitis, and recurrent HSV in higher-risk patients

Common forms: Oral tablets/capsules/suspension, topical cream for cold sores, and intravenous acyclovir for severe or immunocompromised cases under medical care.

This article is for dental education only. Acyclovir treats herpes simplex virus replication; it does not treat aphthous ulcers, oral candidiasis, bacterial abscess, pulpitis, cellulitis, or traumatic ulcers. Oral herpes lesions can be contagious. Elective dental treatment should usually be postponed during active herpetic lesions when safe to do so. Severe disease, dehydration, eye involvement, immunosuppression, spreading lesions, or systemic illness requires medical assessment.

Acyclovir is an antiviral medicine used for infections caused by herpes simplex virus. In dental practice, it is relevant when a patient has cold sores, primary herpetic gingivostomatitis, recurrent intraoral HSV, or HSV risk around dental treatment.

Acyclovir works best when started early, ideally during prodrome or soon after lesions appear. It can shorten symptoms and viral shedding, but it does not remove HSV latency from the body, so recurrence remains possible.

The key clinical principle is: diagnose the lesion before prescribing antivirals. A painful oral ulcer is not automatically herpes. Non-healing, indurated, atypical, or persistent lesions must be assessed rather than repeatedly treated with acyclovir.

• Best dental use: selected HSV-related oral or perioral lesions when early antiviral treatment is appropriate
• Common context: herpes labialis, primary herpetic gingivostomatitis, recurrent oral HSV, immunocompromised patients, dental treatment planning around active cold sores
• Main advantage: reduces viral replication when started early
• Main limitation: less useful when lesions are already crusted/healing or when the diagnosis is not HSV
• Clinical priority: check renal function risk, hydration status, immunosuppression, pregnancy, and red flags

Acyclovir is activated mainly inside HSV-infected cells by viral thymidine kinase. After activation, it interferes with viral DNA synthesis and slows viral replication.

• Target: herpes simplex virus, especially HSV-1 in most oral and labial infections.
• Timing: early treatment is most useful, especially during tingling, burning, prodrome, or very early vesicles.
• Effect: reduces viral replication and may shorten symptoms when used appropriately.
• Limitation: does not eradicate latent HSV from sensory ganglia.
• Important: antivirals do not replace hydration, pain control, oral hygiene support, infection-control precautions, or referral when severe.

• Early treatment of herpes labialis / cold sores when clinically appropriate
• Primary herpetic gingivostomatitis with significant pain, fever, poor oral intake, or early presentation
• Recurrent intraoral HSV in selected patients after diagnosis
• HSV management in immunocompromised patients, usually with medical coordination
• Prevention or suppression planning in patients with frequent severe recurrent herpes, when medically appropriate
• Dental appointment planning when active herpetic lesions are present
• Patient education about contagion, avoiding touching lesions, hand hygiene, and not sharing lip products
• Not a treatment for aphthous ulcers, oral candidiasis, bacterial infections, pulpitis, or dental abscess

Cold sores / herpes labialis: topical acyclovir cream may be used early in non-immunocompromised patients. Benefit is greatest when started at prodrome or early lesion stage.

Primary herpetic gingivostomatitis: oral acyclovir may be considered early, especially when symptoms are severe, the patient is within the early treatment window, or oral intake is affected.

Important: exact dose, duration, formulation, and route depend on age, weight, renal function, immune status, severity, local guidance, and whether urgent medical care is needed.

• Acyclovir: established antiviral, often requires more frequent dosing.
• Valacyclovir: prodrug of acyclovir with better oral bioavailability and often simpler dosing schedules.
• Clinical difference: both require renal caution and dose review in renal impairment.
• Practical choice: depends on guideline, availability, patient adherence, renal function, severity, and prescriber scope.

• Active cold sore: postpone elective dental care when possible to reduce discomfort and cross-infection risk.
• Urgent dental need: treat only if necessary with strict infection-control precautions and patient comfort planning.
• Primary gingivostomatitis: supportive care, hydration, pain control, and medical referral when severe may be more important than routine dental treatment.
• Do not ignore red flags: dehydration, eye symptoms, immunocompromise, severe systemic illness, or spreading lesions require urgent medical assessment.

• Recurrent aphthous ulcers mistaken for herpes
• Traumatic ulcers from sharp teeth, dentures, orthodontics, or cheek biting
• Oral candidiasis, white plaques, or burning mouth not consistent with HSV
• Bacterial dental abscess, cellulitis, or facial swelling
• Irreversible pulpitis or odontogenic toothache
• Non-healing, indurated, red-white, or suspicious oral lesions requiring biopsy/referral
• Late crusted cold sores where antiviral benefit is likely limited
• Severe renal impairment without dose review and hydration advice
• Known hypersensitivity to acyclovir, valacyclovir, or related components
• Self-treatment of severe HSV in immunocompromised patients without medical care

• Known allergy or serious reaction to acyclovir or valacyclovir
• Renal impairment, dehydration, older age, or nephrotoxic medicines without dose and safety review
• Immunocompromised patient with extensive, severe, recurrent, or atypical lesions without medical coordination
• Pregnancy or breastfeeding where prescriber-led risk-benefit assessment is needed
• Neurologic symptoms such as confusion, hallucinations, tremor, or reduced consciousness during therapy
• Suspicion of ocular herpes, keratitis, or eye involvement
• Inability to maintain oral intake or hydration, especially in children
• Repeated courses for undiagnosed lesions

• Renal safety: dose modification is recommended in renal impairment; adequate hydration should be maintained.
• Nephrotoxic medicines: caution is needed with drugs that can affect kidney function.
• Neurologic symptoms: confusion, agitation, hallucinations, tremor, or reduced consciousness need urgent review.
• Immunocompromised patients: severe HSV may require medical or hospital-based treatment, sometimes intravenous acyclovir.
• Ocular herpes: eye pain, redness, photophobia, or visual symptoms require urgent eye/medical assessment.
• Contagion: active lesions can spread by direct contact and contaminated items.
• Dental aerosols/contact: elective treatment should be postponed during active lesions where possible.

• Nephrotoxic medicines: may increase renal dysfunction risk, especially in dehydration or older patients.
• Probenecid: can increase acyclovir exposure by reducing renal clearance.
• Mycophenolate and transplant medicines: medically complex patients need coordination.
• NSAIDs: consider kidney risk when dehydration or renal impairment is present.
• Topical steroids: do not place steroids on undiagnosed herpetic lesions unless directed, because steroids may worsen viral infection.
• Dental procedures: active herpes can complicate appointments through pain, lesion rupture, and transmission risk.

• Headache
• Nausea, vomiting, diarrhoea, or abdominal discomfort
• Dizziness or tiredness
• Skin rash, itching, or photosensitivity-type reactions
• Renal dysfunction risk, especially with dehydration, renal impairment, high doses, or nephrotoxic medicines
• Confusion, agitation, tremor, hallucinations, or other neurologic symptoms, especially in renal impairment or older patients
• Rare allergic reactions such as swelling, wheezing, or severe rash
• Persistent or worsening lesions if the diagnosis is not HSV or if resistance/immunosuppression is present

• Start treatment as early as advised, ideally at tingling, burning, or early blister stage.
• Take the medicine exactly as prescribed and complete the course unless told otherwise.
• Drink enough fluids, especially if taking oral acyclovir tablets.
• Do not touch, pick, or squeeze cold sores; wash hands after contact.
• Avoid kissing, oral sex, sharing lip balm, cups, cutlery, towels, or toothbrushes during active lesions.
• Use sunscreen or lip protection if sunlight triggers cold sores.
• Do not apply steroid creams or strong antiseptics to oral herpes unless directed.
• Postpone routine dental appointments during active cold sores when possible.
• Seek urgent care for eye symptoms, dehydration, severe systemic illness, confusion, or spreading lesions.
• Tell the dentist or physician about kidney disease, pregnancy, breastfeeding, immune suppression, and all medicines.

Acyclovir is most useful when the clinical picture is clearly HSV and the patient presents early. If the lesion is atypical, non-healing, indurated, fixed, red-white, or repeatedly “coming back” in the same suspicious area, think diagnosis and referral — not repeated antiviral courses.

• Eye pain, red eye, photophobia, blurred vision, or lesions near the eye
• Severe primary gingivostomatitis with inability to drink, dehydration, or lethargy
• Immunocompromised patient with extensive, recurrent, necrotic, or spreading HSV lesions
• Fever, severe malaise, neck stiffness, confusion, or neurologic symptoms
• Rapidly spreading facial or oral lesions
• Persistent oral ulceration beyond two weeks
• Suspicious red-white, indurated, fixed, or non-healing lesion
• Severe allergic reaction: swelling, wheezing, rash, fainting, or breathing difficulty
• Reduced urination, flank pain, severe vomiting, or signs of renal toxicity/dehydration
• Severe postoperative outbreak after dental treatment with significant pain or systemic symptoms

• Valacyclovir
• Herpes Labialis / Cold Sores
• Primary Herpetic Gingivostomatitis
• Recurrent Aphthous Stomatitis
• Oral Candidiasis
• Topical Corticosteroids for Oral Medicine
• Immunocompromised Patient
• Postponing Dental Treatment During Active Lesions
• Oral Ulcer Differential Diagnosis
• Antiviral Prescribing Safety

Acyclovir is an antiviral nucleoside analogue used for selected herpes simplex infections affecting the lips and oral cavity. In dental practice it is relevant for herpes labialis, primary herpetic gingivostomatitis, recurrent intraoral HSV, and HSV management in higher-risk patients. It works best when started early and is not useful for aphthous ulcers, candidiasis, bacterial abscesses, pulpitis, or suspicious non-healing lesions. Safety review should include renal impairment, hydration, older age, nephrotoxic drugs, immunosuppression, pregnancy, breastfeeding, eye symptoms, and severe systemic illness. Active oral herpes is contagious, so elective dental care should usually be postponed when possible. Severe, extensive, ocular, dehydrating, or immunocompromised HSV presentations require urgent medical assessment rather than routine dental management alone.